Stark disparities in treatment and survival time for people with pancreatic cancer
04/23/25 at 02:00 AM
Stark disparities in treatment and survival time for people with pancreatic cancer
Cancer Health, Plymouth Meeting, PA; by National Comprehensive Cancer Network; 4/22/25
New research in the April 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network found significant disparities based on race, socioeconomic status, and other factors when it came to quality of care and outcomes for people with metastatic pancreatic adenocarcinoma (mPDAC)—which is associated with very high cancer mortality. The researchers used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to study 14,147 patients who were diagnosed with mPDAC between 2005–2019.